Distribution of Fleroxacin(FLRX) into oral tissues.
スポンサーリンク
概要
- 論文の詳細を見る
Serum and tissue concentrations of fleroxacin (FLRX), a new quinolone antimicrobial agnt, were measured in W ister Strain rats after oral administration at a dose of 10mg/kg. FLRX was detected in serum, gingiva, tongue, mandibular bone, cervical lymphnode, submandibular bone, gland, kidney and liver. Samples were taken at 0.25h, 0.5h, 1h, 2h, 4h, 6h, and 8h, after administration.<BR>The concentrations were determined by bioassay, and a paper disk method was adopted using Escherrichia coli NIHJ JC-2 was the test organism.<BR>The serum and all tissue concentrations reached a peak the 30 minutes and the peak concentration of FLRX was 4.51μg/ml in serum, 2.8μg/g in gingiva, 2.12μg/g in tonve, 3.22μg/g in mandibular bone, 3.5μg/g in cervical lymph node, 5.2μg/g in submandibular gland, 6.34μg/g in kidney, and 14.5μg/g in liver. The ratios of the above tissue levels to the serum level were 0.62, 0.47, 0.71, 0.78, 1.15, 1.41, and 3.22.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果